OHSU, VA Portland study links Parkinson’s disease to Agent Orange exposure
November 16, 2026
Veterans who directly handled the chemical in the Vietnam War are 99% more likely to develop Parkinson’s; highlights long-term health risks of chemical exposure.
Accolades: Awards, honors and accomplishments November
November 16, 2026
Congratulations to Ece Eksi, Eleni Efstathiou, Vijayshree Yadav, OHSU RELATE, John Kaufman, Susan Tolle, Cary Harding, Laurence Trussell, Bita Moghaddam, Ellen Tilden, Skip Bohm and Eric Gouaux.
OHSU research suggests new avenue for gene therapy to treat Parkinson’s
November 11, 2026
Study examines Christchurch mutation in gene previously linked to Alzheimer’s protection.
Accolades: Awards, honors and appointments September
September 21, 2026
Congratulations to Melinda Davis, OHSU Neuro-Oncology Blood-Brain Barrier Program, Ben Burwitz and ONPRC research team, Lia Ernst, Jacob Raber, Miguel Marino, Megan Burger and Eneida Nemecek.
Intermittent fasting shows promise in slowing Huntington’s disease progression
September 17, 2026
OHSU-led pilot study finds time-restricted eating is feasible, safe, linked to improvements in disease markers.
Doernbecher pediatrics - neurology
September 15, 2026
From the moment Frank arrived at OHSU Doernbecher, efforts to determine his condition required expertise and collaboration across various specialties, including family medicine, emergency medicine, urology and neurology. (OHSU)
U.S. News & World Report: OHSU ranked best hospital in Oregon
August 04, 2026
Annual report ranks OHSU adult specialties among the top in the country.
OHSU awarded $6.5 million to improve rural health
July 09, 2026
Six projects are among $97.1 million distributed by the Oregon Health Authority this week.
CAR-T to treat autoimmune conditions, cancer
June 30, 2026
From left: Nizar Chahin, M.D., associate professor of neurology in the OHSU School of Medicine and a specialist in neuromuscular disorders; Vijayshree Yadav, M.D., chair of neurology in the OHSU School of Medicine; and Richard Maziarz, M.D., OHSU professor of medicine and hematologist-oncologist, are helping advance cellular therapies such as CAR-T to treat autoimmune conditions in addition to cancer at Oregon Health & Science University. (OHSU/Christine Torres Hicks)
OHSU advances massive leap in medical science with cellular therapies
June 26, 2026
Patients are benefiting from CAR-T to treat neurodegenerative diseases, cancer, lupus and other autoimmune conditions.